GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioiasis AD (XBUL:BIOA) » Definitions » Enterprise Value

Bioiasis AD (XBUL:BIOA) Enterprise Value : лв32.62 Mil (As of May. 26, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Bioiasis AD Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bioiasis AD's Enterprise Value is лв32.62 Mil. Bioiasis AD's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was лв-0.14 Mil. Therefore, Bioiasis AD's EV-to-EBIT ratio for today is -229.71.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Bioiasis AD's Enterprise Value is лв32.62 Mil. Bioiasis AD's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was лв-0.14 Mil. Therefore, Bioiasis AD's EV-to-EBITDA ratio for today is -229.71.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Bioiasis AD's Enterprise Value is лв32.62 Mil. Bioiasis AD's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was лв0.00 Mil. Therefore, Bioiasis AD's EV-to-Revenue ratio for today is .


Bioiasis AD Enterprise Value Historical Data

The historical data trend for Bioiasis AD's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioiasis AD Enterprise Value Chart

Bioiasis AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.76 11.33 18.17 18.29 18.25

Bioiasis AD Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.15 18.25 18.25 30.12 32.62

Competitive Comparison of Bioiasis AD's Enterprise Value

For the Medical Devices subindustry, Bioiasis AD's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioiasis AD's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioiasis AD's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Bioiasis AD's Enterprise Value falls into.



Bioiasis AD Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Bioiasis AD's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

Bioiasis AD's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioiasis AD  (XBUL:BIOA) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Bioiasis AD's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=32.619/-0.142
=-229.71

Bioiasis AD's current Enterprise Value is лв32.62 Mil.
Bioiasis AD's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв-0.14 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Bioiasis AD's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=32.619/-0.142
=-229.71

Bioiasis AD's current Enterprise Value is лв32.62 Mil.
Bioiasis AD's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв-0.14 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Bioiasis AD's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=32.619/0
=

Bioiasis AD's current Enterprise Value is лв32.62 Mil.
Bioiasis AD's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioiasis AD Enterprise Value Related Terms

Thank you for viewing the detailed overview of Bioiasis AD's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioiasis AD (XBUL:BIOA) Business Description

Traded in Other Exchanges
N/A
Address
60, Deyan Belishki Str., Ground Floor, Sofia, BGR, 1404
Bioiasis AD provides specialized medical devices, equipment, and consultation services to state and private hospitals and trading companies. The company also deals in Interventional Cardiology and General Surgery consumables.

Bioiasis AD (XBUL:BIOA) Headlines

No Headlines